Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-02
2011-08-02
Young, Shawquia E (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S378000, C544S137000, C548S247000
Reexamination Certificate
active
07989450
ABSTRACT:
Isoxazole derivatives, in particular diarylisoxazole derivatives inhibitors of cyclooxygenase (COX), in particular cyclooxygenase-1 (COX-1), their pharmaceutical compositions, the process for their preparation and their use for the chemoprevention and treatment of inflammatory syndromes and in the prevention and treatment of carcinomas, in particular intestinal, ovarian and cutaneous carcinomas, in the treatment of pain syndromes, in particular after surgery, and in the cardiovascular field as antithrombotics/vasoprotectives/cardioprotectives.
REFERENCES:
patent: 4327222 (1982-04-01), Micetich et al.
patent: 5318970 (1994-06-01), Suzuki et al.
patent: 5399577 (1995-03-01), Shindo et al.
patent: 5859257 (1999-01-01), Talley
patent: 5985902 (1999-11-01), Talley et al.
patent: 2005/0131028 (2005-06-01), Carter et al.
patent: 0 026 928 (1981-04-01), None
patent: 0 549 797 (1993-07-01), None
patent: 0 633 254 (1995-01-01), None
patent: 1 251 126 (2002-10-01), None
patent: WO 96/25405 (1996-08-01), None
patent: WO 98/47880 (1998-10-01), None
patent: WO 01/81332 (2001-11-01), None
patent: WO 02/083655 (2002-10-01), None
patent: WO 03/029230 (2003-04-01), None
patent: WO 03/031404 (2003-04-01), None
patent: WO 03/078408 (2003-09-01), None
patent: WO 03/087062 (2003-10-01), None
patent: WO 2004/017968 (2004-03-01), None
patent: WO 2004/037798 (2004-05-01), None
patent: WO 2005/007620 (2005-01-01), None
patent: WO 2005/068442 (2005-07-01), None
Imanishi, et al. Document No. 145:505447, retrieved from CAPLUS on Feb. 26, 2010.
Cho, et al. Document No. 140:339321, retrieved from CAPLUS on Feb. 26, 2010.
Reddy, et al. Document No. 138:321278, retrieved from CAPLUS on Feb. 26, 2010.
Wakefield. Document No. 138:368783, retrieved from CAPLUS on Feb. 26, 2010.
Navarro-Ocana, et al. Document No. 125:195484 retrieved from CAPLUS on Feb. 26, 2010.
Toyokuni, et al. Bioorganic and Medicinal Chemistry Letter. (2005), 15, 4699-4702.
Cancer and Metastasis Reviews (1998), 17(1), 91-106.
Science (1999), vol. 286, 531-537.
Cancer [online], [retrieved on Jul. 6, 2007]. Retrieved from the internet, URL http://www.nlm.nih.gov/medlineplus/cancer.html>.
Cancer [online], [retrieved on Jul. 6, 2007]. Retrieved from the internet, URL; http://en.wikipedia.orglwikilCancer.
Document 145:505447, retrieved from CALPUS on Oct. 7, 2010.
Document No. 93:149330, retrieved from CALPUS on Oct. 7, 2010.
Document No. 67:100041, retrieved from CALPUS on Oct. 7, 2010.
International Search Report in PCT/IB2005/000047 dated Sep. 28, 2005.
Database CA Online; Chemical Abstracts Service, Columbus Ohio; Davies, Mark W. et al, “A regioselective cycloaddition route . . . ”, XP002335580; retrieved from STN Database accession No. 2001:603098 Chem. Abs. RN 374715-26-1 Abstract & Chemical Communications, vol. 17, 2001, pp. 1558-1559.
Roston et al, “Comparison of drug substance impurity profiles generated with extended length columns during packed—column SFC”, Journal of Pharmaceutical and Biomedical Analysis, vol. 26, No. 3, 2001, pp. 339-355, XP002335573, Figure 1.
Talley et al, “4-'5-Methyl-3-phenylisoxazol-4-yl!-benzenesulfonamide, Valdecoxib: A Potent and Selective Inhibitor of COX-2”, Journal of Medicinal Chemistry, vol. 43, No. 5, 2000, pp. 775-777; XP002335574, p. 775.
Talley et al, “N-' '(5-Methy1-3-phenylisoxazol-4-yl)-phenyl!sulfonyl!propanamide, sodium salt, parecoxib sodium: a potent and selective inhibitor of COX-2 for parenteral administration”, Journal of Medicinal Chemistry Scheme 1, vol. 43, No. 9, 2000, pp. 1661-1663, XP002335575 Scheme 1.
Database CA Online, Chemical Abstracts Service, Columbus, Ohio, Bellec et al, “Preparation of trisubstituted isoxazoles by chemical and electrochemical reduction . . . ”, XP002335581 retrieved from STN Database accession No. 1980:426329 Chem. Abs. RNs 37928-17-9, 74048-23-0 abstract.
Di Nunno et al, “Regioselective synthesis and side-chain metallation and elaboration of . . . ”, Tetradedron, Elsevier Science Publishers, Amsterdam, NL, vol. 58, No. 13, Mar. 25, 2002, pp. 2659-2665, XP004344987.
Di Nunno et al, “Novel Synthesis of 3,4-Diarylisoxazole . . . ”, Journal of Medicinal Chemistry, vol. 47, No. 20, 2004, pp. 4881-4890, XP002335576.
Capone Marta Luciana
Di Nunno Leonardo
Patrignani Paola
Scilimati Antonio
Tacconelli Stefania
Nixon & Vanderhye P.C.
Universita Degli Studi Di Bari
Universita' Degli Studi “G.D.'Annunzio”—Chi
Young Shawquia E
LandOfFree
Functionalized diarylisoxazoles inhibitors of ciclooxygenase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Functionalized diarylisoxazoles inhibitors of ciclooxygenase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Functionalized diarylisoxazoles inhibitors of ciclooxygenase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2748113